Distillate Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-185,350
Closed -$38.4M 136
2025
Q4
$38.4M Sell
185,350
-94,567
-34% -$18.7M 1.98% 5
2025
Q3
$51.9M Sell
279,917
-3,692
-1% -$633K 2.69% 2
2025
Q2
$43.3M Buy
283,609
+1,616
+0.6% +$248K 2.32% 3
2025
Q1
$46.8M Sell
281,993
-79,168
-22% -$12.4M 2.4% 4
2024
Q4
$52.2M Sell
361,161
-355,641
-50% -$55.1M 2.57% 3
2024
Q3
$116M Buy
716,802
+374,625
+109% +$59.7M 5.82% 1
2024
Q2
$50M Buy
+342,177
New +$50.9M 2.65% 2
2024
Q1
Sell
-77
Closed -$12.1K 47
2023
Q4
$12.1K Hold
77
2.62% 29
2023
Q3
$12K Buy
+77
New +$12.7K 3.03% 22
2022
Q4
Sell
-100,364
Closed -$16.7M 144
2022
Q3
$16.7M Sell
100,364
-23,770
-19% -$4.02M 2.24% 2
2022
Q2
$22M Buy
124,134
+17,478
+16% +$3.11M 3.15% 1
2022
Q1
$18.9M Buy
106,656
+14,598
+16% +$2.48M 2.69% 2
2021
Q4
$15.7M Buy
92,058
+28,592
+45% +$4.68M 2.64% 3
2021
Q3
$10.2M Buy
63,466
+14,933
+31% +$2.55M 2.73% 1
2021
Q2
$8M Buy
48,533
+5,080
+12% +$841K 2.22% 1
2021
Q1
$7.14M Buy
43,453
+9,228
+27% +$1.49M 2.31% 2
2020
Q4
$5.34M Buy
+34,225
New +$5.05M 2.55% 2

Other funds holding JNJ

Distillate Capital Partners's JNJ Position: Q1 2026 in Review

Distillate Capital Partners sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 185,350 shares — an estimated $38.4M sold.

Distillate Capital Partners first reported a position in JNJ in Q4 2020 and held it in 17 quarters. The position peaked at $116M in Q3 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Distillate Capital Partners reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Distillate Capital Partners sold 185,350 Johnson & Johnson shares in Q1 2026, an estimated $38.4M.
  • Distillate Capital Partners first reported a position in Johnson & Johnson in Q4 2020 and held it in 17 quarters.
  • Distillate Capital Partners's Johnson & Johnson position peaked at $116M in Q3 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Distillate Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.